Ginkgo Bioworks Holdings, Inc., Zymergen Inc. - M&A Call Transcript
Good morning. This is Anna Marie Wagner. I'm the Senior Vice President of Corporate Development at Ginkgo Bioworks. I'm joined by Jason Kelly, our CEO and Co-Founder; and Mark Dmytruk, our CFO.
We're excited to host this special call with you today to update you on 2 exciting new acquisitions that were signed over the weekend. You can see more information in our press releases and Form 8-Ks that were released earlier this morning.
Also as a reminder, during the presentation today, we'll be making forward-looking statements, which involve risks and uncertainties. Please refer to our filings with the Securities and Exchange Commission to learn more about these risks and uncertainties.
And now without further ado, I'll hand it over to Jason.
Thanks, Anna Marie. So our mission at Ginkgo is to make biology easier to engineer. And that's going to be especially important today. So we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |